328 related articles for article (PubMed ID: 33649471)
1. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
2. USP39 stabilizes β-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression.
Wang W; Lei Y; Zhang G; Li X; Yuan J; Li T; Zhong W; Zhang Y; Tan X; Song G
Cell Death Dis; 2023 Jan; 14(1):63. PubMed ID: 36707504
[TBL] [Abstract][Full Text] [Related]
3. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.
Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z
Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma.
Dong X; Han Y; Zhang E; Wang Y; Zhang P; Wang C; Zhong L; Li Q
Aging (Albany NY); 2021 Apr; 13(7):10603-10618. PubMed ID: 33833131
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of pseudogene UPAT leads to hepatocellular carcinoma progression and forms a positive feedback loop with ZEB1.
Xiang L; Huang X; Wang S; Ou H; Chen Z; Hu Z; Huang Y; Li X; Yuan Y; Yang D
Cancer Sci; 2020 Nov; 111(11):4102-4117. PubMed ID: 32808348
[TBL] [Abstract][Full Text] [Related]
7. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling.
Zheng D; Ning J; Deng H; Ruan Y; Cheng F
J Transl Med; 2024 May; 22(1):481. PubMed ID: 38773612
[TBL] [Abstract][Full Text] [Related]
8. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
9. YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma.
Liu X; Chen D; Chen H; Wang W; Liu Y; Wang Y; Duan C; Ning Z; Guo X; Otkur W; Liu J; Qi H; Liu X; Lin A; Xia T; Liu HX; Piao HL
Cancer Commun (Lond); 2021 Jul; 41(7):576-595. PubMed ID: 34110104
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
11. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
[TBL] [Abstract][Full Text] [Related]
12. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
[TBL] [Abstract][Full Text] [Related]
13. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
14. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
[TBL] [Abstract][Full Text] [Related]
15. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.
Peng Z; Ouyang X; Wang Y; Fan Q
BMC Mol Cell Biol; 2022 Apr; 23(1):21. PubMed ID: 35468721
[TBL] [Abstract][Full Text] [Related]
16. USP39 promotes tumorigenesis by stabilizing and deubiquitinating SP1 protein in hepatocellular carcinoma.
Dong X; Liu Z; Zhang E; Zhang P; Wang Y; Hang J; Li Q
Cell Signal; 2021 Sep; 85():110068. PubMed ID: 34197957
[TBL] [Abstract][Full Text] [Related]
17. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.
Luo W; Zhu X; Liu W; Ren Y; Bei C; Qin L; Miao X; Tang F; Tang G; Tan S
Oncotarget; 2016 Dec; 7(52):86420-86432. PubMed ID: 27861158
[TBL] [Abstract][Full Text] [Related]
18. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis.
Wang Y; He D; Yang L; Wen B; Dai J; Zhang Q; Kang J; He W; Ding Q; He D
Biochem Biophys Res Commun; 2015 Jul; 463(3):458-65. PubMed ID: 26043685
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin.
Qin Y; Yu J; Zhang M; Qin F; Lan X
Mol Med Rep; 2019 Mar; 19(3):2297-2306. PubMed ID: 30664206
[TBL] [Abstract][Full Text] [Related]
20. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]